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Abstract
Long-term potentiation (LTP) at synapses of nociceptive nerve fibres is a proposed cellular
mechanism underlying some forms of hyperalgesia. In this review fundamental properties of LTP in
nociceptive pathways are described. The following topics are specifically addressed: A concise
definition of LTP is given and a differentiation is made between LTP and "central sensitisation". How
to (and how not to) measure and how to induce LTP in pain pathways is specified. The signal
transduction pathways leading to LTP at C-fibre synapses are highlighted and means of how to pre-
empt and how to reverse LTP are delineated. The potential functional roles of LTP are evaluated
at the cellular level and at the behavioural level in experimental animals. Finally, the impact of LTP
on the perception of pain in human subjects is discussed.
Background
Long-term potentiation (LTP) is a much studied cellular
model of synaptic plasticity. It is generally defined as the
long-lasting but not necessarily irreversible increase in
synaptic strength [1,2]. At least two different stages of LTP
can be distinguished depending upon its duration and the
signal transduction pathways involved. Early phase LTP is
independent of de-novo protein synthesis and lasts for up
to three hours. Late phase LTP involves protein synthesis
and lasts longer than three hours, up to the life span of an
animal and may involve structural changes at synapses
[3]. Short-term potentiation of synaptic strength lasts less
than half an hour. Synaptic strength is the magnitude of
the post-synaptic response (i.e. the post-synaptic potential
or the post-synaptic current, but not action potential fir-
ing, see below) in response to a pre-synaptic action poten-
tial. LTP can be expressed pre- and/or postsynaptically, i.e.
synaptic strength can increase if the release of neurotrans-
mitter(s) is enhanced and/or if the postsynaptic effects of
the neurotransmitter(s) become stronger [4]. LTP at syn-
apses in hippocampus is the prime model for learning and
memory formation [1]. Recent studies have shown that
LTP can also be induced in pain pathways and may con-
tribute to hyperalgesia caused by inflammation, trauma or
neuropathy. This review deals with the latter form of LTP.
What is "central sensitisation"?
"Central sensitisation" is used in the literature in at least
two mutually exclusive definitions. Some of the authors
use "central sensitisation" as an umbrella term for all
forms of changes within the central nervous system which
ultimately lead to enhanced pain perception. If using this
definition of "central sensitisation" one should keep in
mind that none of the presently known phenomena in the
central nervous system (CNS) which can be observed in
experimental or clinical models of hyperalgesia or allody-
nia has a proven, causative role for the perception of pain.
Thus, all presently proposed mechanisms of "central sen-
sitisation" in this definition would have the status of
hypotheses. This includes but is not be limited to the topic
of the present review, the LTP at C-fibre synapses in the
superficial spinal dorsal horn.
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The task force for taxonomy of the International Associa-
tion for the Study of Pain (IASP) and many other authors
define "central sensitisation" as "an enhanced responsive-
ness of nociceptive neurons in the CNS to their normal
afferent input". This is a very clear-cut definition with little
error-proneness. The mechanisms underlying "central
sensitisation" in this definition can be well studied exper-
imentally. Nociceptive neurons in the CNS may, however,
serve very distinct and also antagonistic functions not all
of which are related to the perception of pain. Some noci-
ceptive neurons are excitatory, others are inhibitory. Spi-
nal nociceptive neurons may project to different areas in
the brain, with a wide spectrum of functions. Other noci-
ceptive spinal neurons may project segmentally to
motoneurons and still other may be interneurons with no
known function at all. A remarkable exception are those
nociceptive neurons which are located in lamina I of the
spinal dorsal horn and which express the NK1 receptor for
substance P, many of which project supraspinally. If these
neurons are destroyed selectively by a toxin conjugated to
substance P, then neither inflammation nor neuropathy
leads to full expression of hyperalgesia [5,6]. Interestingly,
animal responses to acute noxious stimuli are not altered
[5,6]. Thus, these neurons are indispensable for the devel-
opment of hyperalgesia but not essential for acute pain.
Enhanced responsiveness of different nociceptive neurons
in the CNS may thus have distinct and perhaps opposing
consequences on pain. Thus, "central sensitisation"
defined in this way is fundamentally different from the
former definition. Some forms of "central sensitisation"
as defined by the IASP task force could contribute to
hyperalgesia and/or allodynia while other forms may
rather lead to the contrary, i.e. stronger feedback inhibi-
tion and endogenous pain control. Many of the presently
known forms of "central sensitisation" defined in the lat-
ter way would be assigned a yet unknown (if any) role for
pain perception.
An utter confusion is created if the term "central sensitisa-
tion" is used but not defined or when switching from one
definition to the other within the same publication, i.e. if
both definitions are not clearly distinguished. This would
incorrectly imply that any form of enhanced responsive-
ness of nociceptive neurons in the CNS to their normal
afferent input would lead to an enhanced perception of
pain. Before we evaluate the evidence suggesting that a
prolonged increase in synaptic strength at C-fibres con-
tributes to hyperalgesia we will first review the fundamen-
tal properties of LTP in pain pathways.
How to (and how not to) measure LTP
LTP is measured as an increase in mono-synaptically-
evoked post-synaptic currents or potentials in response to
a single pre-synaptic action potential. LTP is often studied
in in vitro preparations which allow reliable recordings of
synaptic strength. Whole-cell patch-clamp recording is
now the most often used technique. It enables some con-
trol over the composition of the intracellular fluid of the
post-synaptic neurons which may be advantageous to
study post-synaptic mechanisms of LTP. If, however a dif-
fusible mediator is involved and dialysis of the post-syn-
aptic neuron has to be avoided, perforated patch-clamp
recordings or intracellular recordings with sharp elec-
trodes can be used. To evaluate LTP at the first synapses in
nociceptive pathways, transverse slices with long dorsal
roots attached can be prepared from lumbar spinal cord of
rats or mice to study mono-synaptic, Aδ-fibre or C-fibre
evoked excitatory postsynaptic potentials or currents in
identified dorsal horn neurons [7,8].
Some aspects of LTP can only be studied in the entire ani-
mal with primary afferent nerve fibres and descending
pathways from the brain intact. In vivo C-fibre-evoked
field potentials can be measured in superficial spinal dor-
sal horn e.g. in response to high intensity electrical stimu-
lation of the sciatic nerve for up to 24 h [9]. These
extracellulary recorded field potentials reflect summation
of post-synaptic, mainly mono-synaptically-evoked cur-
rents but not action potential firing [9,10].
Monitoring presynaptic activity at synapses of primary
afferent nerve fibres is technically quite demanding. In an
attempt to monitor pre-synaptic activity in primary affer-
ents optical recordings techniques have been utilised.
Some voltage-sensitive dyes can be anterogradely trans-
ported in primary afferents to the central terminals mainly
in lamina I [11] and may serve as an indicator for pre-syn-
aptic electrical activity but not for transmitter release.
LTP can not be directly investigated by recording action
potential discharges of post-synaptic neurons, as action
potential firing not only depends upon synaptic strength
but also on membrane excitability and the balance
between excitatory and inhibitory input to the neuron.
For the same reasons poly-synaptically-evoked responses
can generally not be used to study synaptic strength and
changes thereof.
How can LTP be induced in pain pathways?
LTP induction by high frequency electrical nerve stimulation
The most frequently used form of conditioning stimula-
tion to induce LTP at synapses in the brain consists of high
frequency electrical stimulation (HFS, around 100 Hz) of
an input pathway. Likewise, LTP can be induced at spinal
synapses of small diameter primary afferents by condi-
tioning high intensity, high frequency burst-like stimula-
tion (typically 100 Hz bursts given several times for 1 s at
C-fibre strength) both, in vitro and in vivo. In spinal cord
slice preparations, both, Aδ-fibre [7] and C-fibre [8,12]-
evoked responses are potentiated by HFS when post-syn-Molecular Pain 2007, 3:9 http://www.molecularpain.com/content/3/1/9
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aptic neurons are mildly depolarized to -70 to -50 mV.
The same HFS induces, however, long-term depression
(LTD) of Aδ-fibre-evoked responses if cells are hyperpolar-
ized to -85 mV suggesting that the polarity of synaptic
plasticity is voltage-dependent [7].
Neurons in spinal cord lamina I which express the NK1
receptor play a pivotal role for hyperalgesia in behaving
animals [5,6]. Most of these neurons send a projection to
supraspinal areas. Interestingly, HFS induces LTP selec-
tively at C-fibre synapses with lamina I neurons which
express the NK1 receptor and send a projection to the
parabrachial area (Fig. 1). In contrast, HFS fails to induce
LTP at synapses with neurons which express the NK1
receptor and send a projection to the periaqueductal grey
or at synapses with neurons which do not express the NK1
receptor and which have no identified supraspinal projec-
tion [8,12].
HFS at C-fibre intensity of sciatic nerve fibre afferents
induces LTP of C-fibre, but not Aβ-fibre-evoked field
potentials in superficial spinal dorsal horn of adult,
deeply anaesthetized rats [9,13,14]. In contrast, condi-
tioning HFS at A-fibre intensity fails to induce LTP of
either A- or C-fibre-evoked field potentials in intact ani-
mals. In spinalised animals, conditioning HFS at Aδ-fibre
intensity induces, however, LTP of C-fibre-evoked field
potentials [15].
LTP induced by low frequency electrical nerve stimulation
For most of the C-fibre afferents it is not typical to dis-
charge at rates as high as 100 imp. s-1. Some C-fibres may,
however, discharge at these high rates but only for short
periods of time, e.g. at the beginning of a noxious
mechanical stimulus [16]. Many C-fibres discharge at con-
siderably lower rates, around 1–10 imp. s-1, e.g. in
response to an inflammation or an injury [17]. Condi-
tioning stimulation within this lower frequency band is
successfully used to induce LTP at C-fibre synapses. In a
spinal cord-dorsal root slice preparation conditioning
electrical low frequency stimulation (LFS 2 Hz for 2–3
min, C-fibre strength) of dorsal root afferents induces LTP
selectively at C-fibre synapses with lamina I neurons that
express the NK1 receptor and project to the periaqueduc-
tal grey (Fig. 1) [12]. C-fibre synapses with lamina I neu-
rons which express the NK1 receptor and project to the
parabrachial area or with no identified supraspinal projec-
tion are, in contrast, not potentiated by LFS [12]. Thus, the
pattern and the frequency of discharges in C-fibres deter-
mine which synapses at the origin of different ascending
pain pathways are potentiated.
Pairing strong post-synaptic depolarization (to +30 mV)
with low frequency (2 Hz) stimulation of afferent nerve
fibres also leads to a robust LTP in superficial spinal dorsal
horn neurons in vitro [18]. In spinal cord slices from neo-
natal rats field potentials evoked by electrical stimulation
in the tract of Lissauer are potentiated by repetitive burst-
like stimulation at 10 Hz [19].
In deeply anaesthetized adult rats with their spinal cords
left intact LFS (at 2 Hz for 2–3 min) of sciatic nerve fibres
at C-fibre intensity but not at Aδ-fibre intensity also trig-
gers LTP of C-fibre-evoked potentials (Fig. 1) [12].
In conclusion, HFS and LFS may have fundamentally dif-
ferent effects on LTP induction at different C-fibre syn-
apses. This finding is in line with previous reports also
illustrating that the frequency of afferent barrage in C-
fibres may have qualitatively different effects in spinal
cord. For example, brain-derived neurotrophic factor is
released from primary afferents in spinal cord slices in an
activity-dependent manner by HFS at 100 Hz but not by 1
Hz LFS of primary afferent nerve fibres [20]. Furthermore,
in spinal cord slices from mice HFS (100 Hz) of primary
afferent nerve fibres at C-fibre intensity, but not LFS (900
pulses at 1 Hz) selectively induces phosphorylation of
extracellular receptor-activated MAP Kinases (ERK1/2) in
spinal dorsal horn lamina I [21].
Natural noxious stimulation induces LTP in pain pathways
At synapses in the brain LTP induction requires synchro-
nous, high-frequency pre-synaptic activity or pairing of
low-level pre-synaptic activity with strong post-synaptic
depolarization. At least some of the C-fibre synapses are
apparently unique in that LTP can be induced by LFS and
by natural, low or high frequency, asynchronous and
irregular discharge patterns in sensory nerve fibres. In ani-
mals with spinal cord and descending pathways intact,
intraplantar, s.c. injections of capsaicin (100 μl, 1%) or
formalin (100 μl, 5%) induce slowly rising LTP (Fig. 1)
[12].
Some forms of low level afferent input can induce LTP
only if descending, presumably inhibitory pathways are
interrupted or weakened. Noxious radiant heating of the
skin at a hind paw induces LTP in spinalised animals but
not in animals with spinal cord intact [22]. Likewise,
repetitive, noxious squeezing of the skin or the sciatic
nerve induces LTP of C-fibre-evoked field potentials in
spinalised rats only [22]. These findings indicate that
endogenous antinociceptive systems not only raise
thresholds for nociception but also those for the induc-
tion of LTP.
Pharmacological induction of LTP
At C-fibre synapses LTP can also be induced in the absence
of any pre-synaptic activity. Spinal application of a
dopamine 1/dopamine 5 receptor agonist (SKF 38393) in
vivo induces a slowly developing LTP of C-fibre-evokedMolecular Pain 2007, 3:9 http://www.molecularpain.com/content/3/1/9
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A, B show contrasting forms of LTP expressed in distinct groups of spinal lamina I projection neurons in vitro Figure 1
A, B show contrasting forms of LTP expressed in distinct groups of spinal lamina I projection neurons in vitro. Time courses of 
mean amplitudes (± SEM) of C-fibre-evoked EPSCs in lamina I neurons with a projection to the parabrachial area (PB, n = 8) or 
the periaqueductal grey (PAG, n = 7). Conditioning HFS induced LTP in all spino-PB neurons tested (A) but was ineffective in 
spino-PAG neurons (data not shown). Conditioning LFS induced LTP in all 18 spino-PAG neurons tested (B) but was never 
effective in seven spino-PB neurons (data not shown). C-E LTP can be induced by natural, low frequency afferent barrage 
evoked by inflammation of peripheral tissue in vivo. Mean time courses of C-fibre-evoked field potentials recorded extracellu-
lary in superficial spinal dorsal horn in response to electrical stimulation of left sciatic nerve of deeply anaesthetized adult rats 
with spinal cords and afferent nerves intact. Subcutaneous injections of transient receptor potential vanilloid 1 channel agonist 
capsaicin (1%, 100 μl, n = 5, C) or formalin (5%, 100 μl, n = 6, D) into the glabrous skin at the ipsilateral hind paw, within the 
innervation territory of the sciatic nerve at time zero (arrows) induced LTP (closed circles), while injections of the respective 
solvents (open circles) had no effects (n = 3 in each group). Conditioning electrical LFS (2 Hz, 2 min at C-fibre intensity) of sci-
atic nerve at time zero (arrow) induced LTP (n = 28, E) which was prevented by NMDA receptor antagonist MK-801 (3 mg kg-
1, i.v.-infusion over 30 min, data not shown). Modified from [12].
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field potentials which lasts for at least 10 h and which is
blocked by the dopamine 1/dopamine 5 antagonist SCH
23390 [23]. In spinalised, deeply anaesthetized, adult
rats, superfusions of spinal cord segments with NMDA
(10 μM), substance P (10 μM) or neurokinin A (1 μM) are
all sufficient to induce LTP of C-fibre-evoked field poten-
tials [24]. With spinal cord and descending (inhibitory)
pathways intact spinal applications of NMDA (1–100
μM), substance P (1–100 μM) or neurokinin A (1 or 10
μM) fail, however, to induce LTP of C-fibre-evoked field
potentials [24].
LTP of A-fibre-evoked responses
A-fibre-evoked spinal field potentials are depressed by
conditioning 50 Hz stimulation of sciatic nerve fibres.
After GABAA  receptor antagonist bicuculline (1 mg/kg
i.p.) the same conditioning stimulus now produces LTP
rather than LTD [25]. Similarly, 50 Hz conditioning stim-
ulation produces short lasting potentiation followed by
LTD in control animals but LTP in animals with a CCI of
sciatic nerve [26]. Topical application of muscimol (10
μg), a GABAA receptor agonist to spinal cord prevents tet-
anus-induced LTP of A-fibre-evoked field potentials in
animals with a CCI [27]. This again suggests that the
polarity of synaptic plasticity is context-sensitive and not
solely dominated by the type of afferent input.
Signal transduction pathways leading to LTP at C-fibre 
synapses
In principle, LTP can be induced and/or expressed by pre-
synaptic [28] or by post-synaptic [29,30] mechanisms or
by any combination thereof. At present, there is clear evi-
dence for a post-synaptic, Ca2+-dependent form of LTP
induction in spinal cord lamina I neurons. Induction of
LTP at C-fibre-synapses requires co-activation of NK1 and
NK2 receptors [9], opening of ionotropic glutamate recep-
tors of the NMDA type [8,12,13], opening of T-type volt-
age-gated calcium channels [8,12], and activation of
group I but not group II or III metabotropic glutamate
receptors [31]. Activation of NK1 receptors by substance P
may directly enhance single NMDA channel opening [32]
and NMDA receptor mediated currents in lamina I neu-
rons [8] and all this may lead to substantial rise in post-
synaptic [Ca2+]i (Fig. 2). It is presently unknown if Ca2+
influx through Ca2+-permeable a-amino-3-hydroxy-5-
methyl-4-isoxazolepropionic acid (AMPA) receptors is
required for LTP induction in pain pathways. Some indi-
rect evidence suggests, however, that this might be the
case [21,33].
In any case, a rise in post-synaptic [Ca2+]i is essential for
LTP induction and the magnitude in [Ca2+]i rise is linearly
correlated with the magnitude of LTP in vitro [8]. Recent
data demonstrate that LTP-inducing stimuli cause sub-
stantial rise in [Ca2+]i in lamina I neurons not only in slice
preparations, but also in intact animals [12]. Not surpris-
ingly therefore signal transduction involves Ca2+-depend-
ent pathways including activation of protein kinase C,
calcium-calmodulin-dependent protein kinase II (CaM-
KII), protein kinase A (PKA) phospholipase C (PLC),
inositoltriphosphate-3 (IP3) receptors, nitric oxide syn-
thase (NOS) and members of the mitogen-activated pro-
tein kinase family (MAPK), including extracellular signal-
regulated kinase (ERK) (Fig. 2) [8,12,18,34-36].
When assessed with voltage-sensitive dyes the pre-synap-
tic facilitation of electrical activity in primary afferents
after LTP-inducing stimuli is partially sensitive to iNOS
inhibitor (AMT), a blocker of glial cell metabolisms
(MFA), and an mGluR group I antagonist (LY367385)
[11].
Inhibition of protein synthesis in spinal cord by either
cycloheximide or anisomycin selectively inhibits the
maintenance of the late-phase of spinal LTP but does not
affect either LTP induction or baseline responses of C-
fibre evoked field potentials [37].
Importantly, the very same signal transduction pathways
are required for full expression of hyperalgesia in animal
models of inflammatory and neuropathic pain e.g. [38-
41].
How to pre-empt LTP induction in pain pathways
LTP induction can be prevented by blockade of any of the
above mentioned essential elements of signal transduc-
tion for LTP. In mature rats deep (surgical) level of anaes-
thesia with either urethane, isoflurane or sevoflurane is,
however, insufficient to pre-empt LTP induction of C-
fibre-evoked field potentials [42]. LTP is prevented by low
dose intravenous infusion of μ-opioid receptor agonist
fentanyl [42]. Similarly, LTP of spinal field potentials elic-
ited by stimulation in the tract of Lissauer in spinal cord
slices is blocked by DAMGO, a more specific agonist at
these receptors [19]. Activation of spinal a2-adrenorecep-
tors by clonidine [43] or spinal application of the benzo-
diazepine diazepam [44] also prevents LTP induction in
vivo.
Functional blockade of glial cells by i.t. administration of
fluorocitrate changes the polarity of HFS induced synaptic
plasticity. When HFS is given 1 h, but not 3 h after fluor-
ocitrate LTD but no LTP of C-fibre-evoked field potentials
is induced [14].
LTP can be reversed
LTP of C-fibre-evoked field potentials can be reversed by
brief, high frequency conditioning electrical stimulation
of sciatic nerve fibres at Aδ-fibre intensity [15]. Reversal of
LTP by Aδ-fibre stimulation is time-dependent and effec-Molecular Pain 2007, 3:9 http://www.molecularpain.com/content/3/1/9
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tive only when applied 15 or 60 min but not 3 h after LTP
induction [45].
Spinal application of either, NK1 or NK2 receptor antago-
nists one to three hours after HFS, i.e., after LTP is estab-
lished, does not affect maintenance of LTP [9], suggesting
that activation of these receptors, which are required for
the induction of LTP are not essential for its maintenance.
What is the functional role of LTP in pain pathways?
Modulation of synaptic strength is a powerful mechanism
to control signal flow in selected pathways. A typical con-
sequence of LTP at excitatory synapses would be an
increase in action potential firing of the same and perhaps
also of downstream neurons in response to a given stimu-
lus. And indeed, LTP-inducing conditioning stimuli have
been found to facilitate action potential firing of multire-
ceptive neurons in deep dorsal horn e.g. [46-48]. This is
likely due to LTP at the first synapse in the nociceptive
pathway but other mechanisms of facilitation should not
be excluded. Action potential firing would also be
enhanced if membrane excitability is increased, i.e. the
thresholds for action potential firing are lowered, if inhi-
bition is less effective or if inhibition is even reversed and
Potential mechanisms of potentiation, prevention and de-potentiation at synapses between C-fibres and spinal cord projection  neurons Figure 2
Potential mechanisms of potentiation, prevention and de-potentiation at synapses between C-fibres and spinal cord projection 
neurons. Conditioning electrical nerve stimulation or natural noxious stimulation triggers release of glutamate and substance P 
which causes opening of NMDA receptor channels and T-type voltage-gated Ca2+ channel and Ca2+ release from intracellular 
stores. This activates Ca2+-dependent signal transduction pathways including protein kinases and transcription factors. Synaptic 
strength is probably increased by phosphorylation of synaptic proteins including AMPA receptor channels [55], altered traffick-
ing of synaptic proteins, e.g. increased insertion of AMPA receptors into the sub-synaptic membrane [56] and de-novo protein 
synthesis. According to this model, LTP can be prevented if release of glutamate and/or substance P is inhibited, for example by 
activation of pre-synaptic, G-protein-coupled μ-opioid receptors, or if opening of voltage sensitive and Ca2+ permeable ion 
channels is blocked, e.g. via postsynaptic inhibition by an opioid. Depotentiation could result from de-phosphorylation of synap-
tic proteins, changes in receptors trafficking and degradation of synaptic proteins.
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becomes excitatory e.g. due to a reversal of the anion gra-
dient in the post-synaptic neuron [49,50].
HFS of sciatic nerve fibres which induces LTP at synapses
of C-fibres in spinal cord has behavioural consequences in
rats and causes thermal hyperalgesia at the ipsilateral hind
paw for six days [34]. This suggests that LTP at C-fibre syn-
apses has an impact on nociceptive behaviour.
Perceptual correlates of LTP in pain pathways in human 
subjects
An indispensable proof for any proposed mechanism of
hyperalgesia is an appropriate correlate in the human.
And indeed, conditioning HFS of cutaneous peptidergic
afferents in humans cause increased pain perception in
response to electrical test stimuli applied through the
same stimulation electrode [51]. Noxious stimulation
with punctate mechanical probes in skin adjacent to the
HFS conditioning skin site uncovers a marked (2–3 fold)
increase in pain sensitivity, i.e. secondary hyperalgesia
[51]. Touching the skin around the conditioning stimula-
tion electrode with a soft cotton wisp evokes pain only
after HFS. Thus, HFS also induces secondary mechanical
allodynia. Hyperalgesia at the conditioned site but not
secondary hyperalgesia or allodynia at adjacent skin areas
is prevented by pre-treatment with ketamine [52], a clini-
cally used substance which, among other effects, also
blocks NMDA receptors.
Interestingly, all thermal modalities comprising cold and
warm detection thresholds, cold and heat pain thresholds
as well as pain summation (perceptual "wind-up")
remain unaltered after conditioning HFS of peptidergic
skin nerve fibres [53].
When verbal pain descriptors are used to evaluate pain in
addition to its perceived intensity after HFS, a significant
long-term increase in scores for sensory but not for affec-
tive descriptors of pain is detected [54]. Within the sen-
sory descriptors, those describing superficial pain, those
for heat pain and those for sharp mechanical pain are all
potentiated. The authors conclude that brief painful stim-
uli rarely have a strong affective component and that per-
ceived pain after HFS exhibits predominantly a
potentiation of the C-fibre-mediated percepts hot and
burning [54].
In humans subjects conditioning LFS causes also an
increased pain sensitivity in the area around the LFS con-
ditioned skin site but a depression of pain evoked by stim-
ulation through the same electrode [51].
Conclusion
LTP at synapses between primary afferent C-fibres and a
group of nociceptive neurons in spinal cord lamina I
which express the NK1 receptor for substance P is a poten-
tial mechanism underlying some forms of pain amplifica-
tion in behaving animals and perhaps human subjects.
Both, LTP and hyperalgesia involve the same essential ele-
ments, i.e. primary afferent C-fibres and lamina I neurons
which express the NK1 receptor. Further, induction proto-
cols, pharmacological profile and signal transduction
pathways are virtually identical.
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